ROTTERDAM, THE NETHERLANDS -- River Diagnostics B. V., today announced the appointment of Michael Rumbin as President and General Manager of their newly formed River Diagnostics, Inc. subsidiary in Simi Valley, California. Mr. Rumbin will report directly to River Diagnostics B. V., C.E.O., Gerwin Puppels and the C.F.O., Ad Prins.
"We are pleased to appoint Michael Rumbin as President and General Manager of the U.S. River Diagnostics, Inc. Business Unit," stated Dr. Puppels. "This new role will expand Michael's responsibilities beyond his current position as Director Business Development, Microbiology, and provide the guidance and leadership for our business activities in the United States. Michael brings to River Diagnostics a wealth of experience in global marketing, sales and long-range business planning. His experience managing global product lines for Baxter, Dade Behring, and IRIS have already proven to be a great asset to the company."
"River Diagnostics is a very attractive opportunity for many reasons," stated Mr. Rumbin. "This unique, enabling technology has already proven itself in the personal care market. I am looking forward to launching a new product that will provide timely, actionable information to aid in the spread and prevention of MRSA and other hospital acquired bacterial infections."
During his tenure at Baxter, Dade Behring and IRIS Diagnostics, Mr. Rumbin held numerous Vice President executive positions, including VP Customer Operations, VP New Business Development and VP Global Marketing. Prior to this position, Mr. Rumbin was the head of his own consulting business, OMEGA Biomedical.
Mr. Rumbin earned a bachelor's in chemistry from Drew University, Madison New Jersey. He has a master's in chemistry from Villanova University, Villanova PA, and a certificate in business administration from The Wharton School, University of Pennsylvania, Philadelphia, PA.
About River Diagnostics B.V.
River Diagnostics develops and brings innovative solutions for clinical diagnostics and life sciences R&D to market, based on the vast potential of Raman spectroscopy for cell and tissue characterization. The company was founded in 2002 as a spinout of the Center for Optical Diagnostics and Therapy of the Erasmus-university Medical Center in Rotterdam, The Netherlands, with which it continues to maintain a close working relationship.
For more information, please call Gerwin Puppels at +31-10-408-9267